Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging.

Acta Neuropathol Commun · 2023 · PMC9835248 · PMID 36631900

Europe PMC DOI

hedged sentence

0.1793

closest p · 3.6× alpha

0.1793

boldest claim

The sentences

a strong trendp = 0.1793not close (p > 0.1)

When we analysed overall survival (OS) data, however, we found a strong trend between fumarate detection and poor outcome in Group 3 MB patients compared to no association in SHH patients ( p = 0.1793 versus p = 0.661, Fig. 7 a, b).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.